New England Regional Coordinating Center for the NINDS Stroke Trials Network
NINDS 卒中试验网络新英格兰地区协调中心
基本信息
- 批准号:9571496
- 负责人:
- 金额:$ 37.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-01 至 2023-07-31
- 项目状态:已结题
- 来源:
- 关键词:AchievementAcuteAddressAdultAdvocacyAmerican Heart AssociationAreaBlood VesselsBostonCaringChildChildhoodClinicalClinical InvestigatorClinical ResearchClinical TrialsClinical Trials NetworkClinical and Translational Science AwardsCollaborationsCommunity HospitalsComplementDisciplineDiscipline of NursingEducational ActivitiesEmergency MedicineEnrollmentEnvironmentFacultyFundingFutureGeneral HospitalsGoalsHealthHospitalsInpatientsInstitutionInternationalInvestigationIsraelLeadLeadershipLettersMaineMassachusettsMedicalMedical centerMissionMulticenter TrialsNational Institute of Neurological Disorders and StrokeNeurologistNeurologyNew EnglandOperative Surgical ProceduresPatient CarePatient-Focused OutcomesPatientsPediatric HospitalsPediatricsPerformancePhasePhase III Clinical TrialsPhysiciansPopulation HeterogeneityPopulations at RiskPositioning AttributePrincipal InvestigatorProtocols documentationPublic HealthRecording of previous eventsRecordsRecoveryRecurrenceRehabilitation therapyResearchResearch ActivityResearch InfrastructureResearch InstituteResearch PersonnelResearch TrainingResourcesRiskRoleRural HospitalsScienceSeasonsSiteStrokeStroke preventionStrokeNet clinical trialsStudy SectionTalentsTestingTherapeuticTrainingTraining and InfrastructureTranslatingTranslational ResearchUnited States National Institutes of HealthUniversitiesVisionWomanbasedesignearly phase trialexperiencefallsimprovedimproved outcomeinnovationmedical specialtiesmembermetropolitanmultidisciplinarynetwork modelsneuroimagingneurosurgerynext generationnovelnovel therapeuticspatient populationpre-clinicalprogramsrecruitresearch studyskillsstroke clinical trialsstroke rehabilitationstroke trialssuccess
项目摘要
We propose to continue the New England Regional Coordinating Center (NERCC), an integrated team of
hospitals and EMS agencies in Boston and Western Massachusetts that will serve as a top-enrolling site and
vibrant contributor to the NINDS Stroke Trials Network. Our group includes many of the major adult academic
stroke centers in the Greater Boston area, and our 30+ hospital New England TeleStroke referral network will
extend our potential recruitment even further. All core hospitals have a proven track record of successful
management and performance of clinical trials. In particular, all hospitals have an established research
infrastructure that performs ongoing clinical research in stroke neurology with strong collaborations across
disciplines. Principal investigator Lee H. Schwamm, MD, and Co-Investigators bring a complementary set of
skills in managing successful translational clinical research programs, membership on Steering Committees,
and positions of national leadership in their fields. Our team includes seasoned clinical investigators in vascular
neurology, emergency medicine, neuroendovascular, neurosurgery, neurointensive care, neuroimaging, stroke
rehabilitation, and preclinical basic and translational stroke investigation in both adults and children. Strengths
of the NERCC team include 1) close personal and professional ties between multiple investigators; 2) large
patient population from diverse hospital settings in a major metropolitan area; 3) talented teams of site
investigators with track records of scientific achievement, innovation, and subject recruitment in multicenter
trials; 4) robust existing NINDS-funded research and clinical trial management infrastructure; 5) existing clinical
research programs, e.g., Neurology Clinical Research Institute, NIH Clinical and Translational Science Award
programs at Boston University and across Harvard; Sites in the SIREN and NeuroNEXT Clinical Coordinating
Center. Overall, the NERCC Team has demonstrated outstanding commitment and performance in the first
StrokeNet cycle, and has the resources, vision, and enthusiasm to continue to develop new translational
science and successfully execute the NINDS StrokeNet Phase 1,2 and 3 trials.
我们建议继续建立新英格兰地区协调中心(NERCC),这是一个由以下人员组成的综合团队:
波士顿和马萨诸塞州西部的医院和 EMS 机构将作为主要招生地点,
NINDS 中风试验网络的活跃贡献者。我们的团队包括许多主要的成人学者
大波士顿地区的中风中心以及我们 30 多家医院新英格兰 TeleStroke 转诊网络将
进一步扩大我们的潜在招聘范围。所有核心医院均拥有良好的成功记录
临床试验的管理和执行。特别是,所有医院都有既定的研究
正在进行中风神经病学临床研究的基础设施,并与各个领域进行强有力的合作
学科。首席研究员 Lee H. Schwamm 医学博士和联合研究员带来了一套互补的
管理成功的转化临床研究项目的技能、指导委员会的成员资格、
以及在各自领域的国家领导地位。我们的团队包括经验丰富的血管临床研究人员
神经内科、急诊医学、神经内血管、神经外科、神经重症监护、神经影像学、中风
成人和儿童的康复、临床前基础和转化性中风研究。优势
NERCC 团队的成员包括 1) 多名研究者之间密切的个人和专业联系; 2)大
来自主要大都市地区不同医院环境的患者群体; 3)现场优秀团队
具有多中心科学成就、创新和受试者招募记录的研究人员
试验; 4) 强大的现有 NINDS 资助的研究和临床试验管理基础设施; 5)现有临床
研究项目,例如神经病学临床研究所、NIH 临床和转化科学奖
波士顿大学和哈佛大学的项目; SIREN 和 NeuroNEXT 临床协调站点
中心。总体而言,NERCC团队在第一届比赛中表现出了出色的承诺和表现
StrokeNet 周期,并拥有资源、愿景和热情来继续开发新的转化
科学并成功执行了 NINDS StrokeNet 1、2 和 3 期试验。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Field Assessment Stroke Triage for Emergency Destination: A Simple and Accurate Prehospital Scale to Detect Large Vessel Occlusion Strokes.
- DOI:10.1161/strokeaha.116.013301
- 发表时间:2016-08
- 期刊:
- 影响因子:8.3
- 作者:Lima FO;Silva GS;Furie KL;Frankel MR;Lev MH;Camargo ÉC;Haussen DC;Singhal AB;Koroshetz WJ;Smith WS;Nogueira RG
- 通讯作者:Nogueira RG
Frequency, predictors and cardiovascular outcomes associated with transthoracic echocardiographic findings during acute ischaemic stroke hospitalisation.
- DOI:10.1136/svn-2021-001170
- 发表时间:2022-12
- 期刊:
- 影响因子:5.9
- 作者:
- 通讯作者:
Comparing prognostic strength of acute corticospinal tract injury measured by a new diffusion tensor imaging based template approach versus common approaches.
- DOI:10.1016/j.jneumeth.2015.09.005
- 发表时间:2016-01-15
- 期刊:
- 影响因子:3
- 作者:Hirai KK;Groisser BN;Copen WA;Singhal AB;Schaechter JD
- 通讯作者:Schaechter JD
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lee H Schwamm其他文献
Breaking up is hard to do: tenecteplase in acute stroke
分手很难做到:替奈普酶治疗急性中风
- DOI:
10.1016/s1474-4422(15)70036-0 - 发表时间:
2015 - 期刊:
- 影响因子:0
- 作者:
Lee H Schwamm - 通讯作者:
Lee H Schwamm
Lee H Schwamm的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lee H Schwamm', 18)}}的其他基金
New England Regional Coordinating Center for the NINDS Stroke Trials Network
NINDS 卒中试验网络新英格兰地区协调中心
- 批准号:
9753384 - 财政年份:2018
- 资助金额:
$ 37.78万 - 项目类别:
New England Regional Coordinating Center for the NINDS Stroke Trials Network
NINDS 卒中试验网络新英格兰地区协调中心
- 批准号:
10306037 - 财政年份:2018
- 资助金额:
$ 37.78万 - 项目类别:
New England Regional Coordinating Center for the NINDS Stroke Trials Network
NINDS 卒中试验网络新英格兰地区协调中心
- 批准号:
9343382 - 财政年份:2016
- 资助金额:
$ 37.78万 - 项目类别:
New England Regional Coordinating Center for the NINDS Stroke Trials Network
NINDS 卒中试验网络新英格兰地区协调中心
- 批准号:
8662842 - 财政年份:2013
- 资助金额:
$ 37.78万 - 项目类别:
New England Regional Coordinating Center for the NINDS Stroke Trials Network
NINDS 卒中试验网络新英格兰地区协调中心
- 批准号:
8890256 - 财政年份:2013
- 资助金额:
$ 37.78万 - 项目类别:
New England Regional Coordinating Center for the NINDS Stroke Trials Network
NINDS 卒中试验网络新英格兰地区协调中心
- 批准号:
8738738 - 财政年份:2013
- 资助金额:
$ 37.78万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 37.78万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 37.78万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 37.78万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 37.78万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 37.78万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 37.78万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 37.78万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 37.78万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 37.78万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 37.78万 - 项目类别:
Standard Grant














{{item.name}}会员




